Quarterly report · Q1

Period2022-03-01 → 2022-05-31
Filed2022-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥24.9bn2022-03-01 → 2022-05-31Cons.Net sales
Revenue¥110.7bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥27.2bn2021-03-01 → 2021-05-31Cons.Net sales
Operating income¥314m2022-03-01 → 2022-05-31Cons.Operating income
Operating income¥538m2021-03-01 → 2021-05-31Cons.Operating income
Ordinary income¥335m2022-03-01 → 2022-05-31Cons.Ordinary income
Ordinary income¥1.2bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥547m2021-03-01 → 2021-05-31Cons.Ordinary income
Profit before tax¥300m2022-03-01 → 2022-05-31Cons.Income before income taxes
Profit before tax¥544m2021-03-01 → 2021-05-31Cons.Income before income taxes
Net income (owners)¥182m2022-03-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥368m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥355m2021-03-01 → 2021-05-31Cons.Profit loss attributable to owners of parent
Net income¥182m2022-03-01 → 2022-05-31Cons.Profit loss
Net income¥355m2021-03-01 → 2021-05-31Cons.Profit loss
Total assets¥49.3bnat 2022-05-31Cons.Assets
Total assets¥49.4bnat 2022-02-28Cons.Assets
Total assets¥50.1bnat 2021-05-31Cons.Total assets (5-year summary)
Total liabilities¥20.4bnat 2022-05-31Cons.Liabilities
Total liabilities¥20.6bnat 2022-02-28Cons.Liabilities
Net assets / equity¥28.9bnat 2022-05-31Cons.Net assets
Net assets / equity¥28.8bnat 2022-02-28Cons.Net assets
Net assets / equity¥28.9bnat 2021-05-31Cons.Net assets (5-year summary)
Cash and deposits¥6.0bnat 2022-05-31Cons.Cash and deposits
Cash and deposits¥6.1bnat 2022-02-28Cons.Cash and deposits
EPS (basic)¥16.72022-03-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥33.762021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥32.662021-03-01 → 2021-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.692022-03-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥33.742021-03-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥32.632021-03-01 → 2021-05-31Cons.Diluted earnings per share (5-year summary)
Equity ratio58.6%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.3%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio57.7%at 2021-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-03-01 → 2022-05-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-03-01 → 2022-05-31¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-03-01 → 2022-05-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-03-01 → 2022-05-31¥20m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-05-31−¥1.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-05-31−¥1.2bn
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-05-31−¥11m
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentrevenue2022-03-01 → 2022-05-31¥3.2bn
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentrevenue external2022-03-01 → 2022-05-31¥3.2bn
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥0
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentsegment profit2022-03-01 → 2022-05-31¥9m
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentrevenue2022-03-01 → 2022-05-31¥21.8bn
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentrevenue external2022-03-01 → 2022-05-31¥21.6bn
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥149m
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentsegment profit2022-03-01 → 2022-05-31¥297m
—segment totalrevenue2022-03-01 → 2022-05-31¥25.0bn
—segment totalrevenue external2022-03-01 → 2022-05-31¥24.9bn
—segment totalrevenue intersegment2022-03-01 → 2022-05-31¥149m
—segment totalsegment profit2022-03-01 → 2022-05-31¥306m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-05-31¥26.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-05-31¥24.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-05-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-05-31¥326m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-03-01 → 2021-05-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-03-01 → 2021-05-31¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-03-01 → 2021-05-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-03-01 → 2021-05-31¥21m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-05-31−¥1.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-05-31−¥1.3bn
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-05-31¥9m
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentrevenue2021-03-01 → 2021-05-31¥3.3bn
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentrevenue external2021-03-01 → 2021-05-31¥3.3bn
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥0
jpcrp040300-q1r_E03228-000Drugstore Businessreportable segmentsegment profit2021-03-01 → 2021-05-31¥9m
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentrevenue2021-03-01 → 2021-05-31¥24.1bn
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentrevenue external2021-03-01 → 2021-05-31¥23.9bn
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥237m
jpcrp040300-q1r_E03228-000Supermarket Businessreportable segmentsegment profit2021-03-01 → 2021-05-31¥498m
—segment totalrevenue2021-03-01 → 2021-05-31¥27.4bn
—segment totalrevenue external2021-03-01 → 2021-05-31¥27.2bn
—segment totalrevenue intersegment2021-03-01 → 2021-05-31¥237m
—segment totalsegment profit2021-03-01 → 2021-05-31¥508m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-05-31¥28.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-05-31¥27.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-05-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-05-31¥529m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 358
ItemContextValueUnit
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-05-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-05-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-05-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass